Zobrazeno 1 - 10
of 26
pro vyhledávání: '"María de Jesús Ibarra-Sánchez"'
Autor:
Héctor I. Saldivar-Cerón, Olga Villamar-Cruz, Claire M. Wells, Ibrahim Oguz, Federica Spaggiari, Jonathan Chernoff, Genaro Patiño-López, Sara Huerta-Yepez, Mayra Montecillo-Aguado, Clara M. Rivera-Pazos, Marco A. Loza-Mejía, Alonso Vivar-Sierra, Paola Briseño-Díaz, Alejandro Zentella-Dehesa, Alfonso Leon-Del-Rio, Alejandro López-Saavedra, Laura Padierna-Mota, María de Jesús Ibarra-Sánchez, José Esparza-López, Rosaura Hernández-Rivas, Luis E. Arias-Romero
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2022)
p21-Activated kinase-1 (Pak1) is frequently overexpressed and/or amplified in human breast cancer and is necessary for transformation of mammary epithelial cells. Here, we show that Pak1 interacts with and phosphorylates the Calcium/Calmodulin-depend
Externí odkaz:
https://doaj.org/article/ec87f1dbc3d246fe88a90ccb748ac16d
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
Autor:
José Esparza-López, Juan Francisco Alvarado-Muñoz, Elizabeth Escobar-Arriaga, Alfredo Ulloa-Aguirre, María de Jesús Ibarra-Sánchez
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Breast cancer currently is the most frequently diagnosed neoplasm and the leading cause of death from cancer in women worldwide, which is mainly due to metastatic disease. Increasing our understanding of the molecular mechanisms l
Externí odkaz:
https://doaj.org/article/2e91f2da99894db693d28287841ab827
Autor:
María G. C. Navarrete-Bernal, Mayte G. Cervantes-Badillo, Jose Fabián Martínez-Herrera, César O. Lara-Torres, Raquel Gerson-Cwilich, Alejandro Zentella-Dehesa, María de Jesús Ibarra-Sánchez, José Esparza-López, Juan J. Montesinos, Víctor Adrián Cortés-Morales, Diego Osorio-Pérez, Diana A. Villegas-Osorno, Eduardo Reyes-Sánchez, Pablo Salazar-Sojo, Luis F. Tallabs-Utrilla, Sandra Romero-Córdoba, Leticia Rocha-Zavaleta
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Patients with triple-negative breast cancer (TNBC) have a poor prognosis, partly because of the absence of targeted therapies. Recognition of the key role of immune responses against cancer has allowed the advent of immunotherapy, focused on the inhi
Externí odkaz:
https://doaj.org/article/f15f17fd5d6c4186a7abe754e5cbd50e
Autor:
José Esparza-López, María de Jesús Ibarra-Sánchez, Juan Francisco Alvarado-Muñoz, Eucario León-Rodríguez, Eliseo Neftali De la Cruz-Escobar, Elizabeth Escobar-Arriaga
Publikováno v:
Gaceta Mexicana de Oncolog�a. 16
Autor:
José Esparza-López, Elizabeth Escobar-Arriaga, Eucario León-Rodríguez, Eliseo Neftali De la Cruz-Escobar, Juan Francisco Alvarado-Muñoz, María de Jesús Ibarra-Sánchez
Publikováno v:
Gaceta Mexicana de Oncolog�a. 16
El cancer de mama es la primera causa de muerte por cancer en Mexico. La mayoria de las muertes se relacionan con la forma de presentacion de la enfermedad como localmente avanzada o metastasica. La transicion epitelio-mesenquima (TEM) es uno de los
Autor:
Víctor A. Sosa-Hernandez, Lilia G. Noriega, Juan Martínez-Aguilar, José L. Maravillas-Montero, María de Jesús Ibarra-Sánchez, Alain Aguilar-Valdés, Armando R. Tovar
Publikováno v:
Biochemical and Biophysical Research Communications. 552:23-29
Pancreatic cancer remains one of the most lethal diseases with dismal five-year survival rates. Although mutant KRas protein-driven activation of downstream MAPK Raf/MEK/ERK and PI3K/Akt signaling pathways represent major oncogenic alterations, signa
Publikováno v:
Revista de investigaci�n Cl�nica. 71
Cancer is the second-leading cause of death in the world, accounting for one out of six deaths. Consequently, there is an urgent need for new and more effective therapeutic options as well as drug screening methods. Immortal, "stable" cancer cell lin
Publikováno v:
Cancer Research. 81:1416-1416
Metformin is an oral antidiabetic drug with a putative antineoplastic effect in breast cancer; however, its efficacy in clinical trials has been mixed. Triple negative breast cancer (TNBC) is an aggressive disease with poor outcomes for which new tre
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
Autor:
María de Jesús Ibarra-Sánchez, Elizabeth Escobar-Arriaga, Alfredo Ulloa-Aguirre, Juan Francisco Alvarado-Muñoz, José Esparza-López
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Background Breast cancer currently is the most frequently diagnosed neoplasm and the leading cause of death from cancer in women worldwide, which is mainly due to metastatic disease. Increasing our understanding of the molecular mechanisms leading to
Autor:
Eucario León-Rodríguez, Andrea Castro-Sanchez, María de Jesús Ibarra-Sánchez, Brizio Moreno-Jaime, Elizabeth Escobar-Arriaga, José Esparza-López, Heriberto Medina-Franco
Publikováno v:
Gaceta Mexicana de Oncología. 15(1):10-15
ResumenAntecedentesLa transición epitelio-mesénquima (TEM) es un proceso biológico en el que células epiteliales inmóviles y polarizadas se convierten en células mesenquimales con capacidad de migración. Este proceso produce cambios en el cito